Comparison
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 vs 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Clinical comparison between 46 XY Disorder OF Sex Development Due TO A Cholesterol Synthesis Defect and 45 X 46 XY Mixed Gonadal Dysgenesis CN279762 for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
A genetic condition impairing cholesterol synthesis, affecting sex hormone production. Typically part of Smith-Lemli-Opitz syndrome. Treatment focuses on cholesterol supplementation and hormone support.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
A chromosomal variation affecting sexual development. Involves differences in gonadal tissue and may affect physical development. Care involves hormonal support and multidisciplinary management.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
0-0
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
0-0
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
severe
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
Chronic
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
No
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
reproductive
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
reproductive
Same/different system
Category
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
metabolic
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-a-cholesterol-synthesis-defect-C5679868 and 45-x-46-xy-mixed-gonadal-dysgenesis-CN279762 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Discriminating power |
|---|---|---|---|
| Genital phenotype | 46,XY DSD may include undervirilization, often with other congenital anomalies. | Phenotype ranges from female-appearing to ambiguous or male-appearing genitalia. | Moderate |
| Associated features | May include growth, developmental, and congenital anomalies typical of a cholesterol-synthesis disorder. | May include short stature, Turner-like features, or asymmetric gonadal development. | Moderate |
| Gonadal findings | Gonads are not defined by mosaicism; hormone production may be impaired. | Mixed gonadal tissue, including streak and testicular elements, may occur. | High |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 when
46,XY karyotype with suspected metabolic syndrome
Cholesterol-pathway testing and syndrome evaluation are more relevant than mosaicism studies alone.
Moderate
Multiple congenital anomalies plus undervirilization
The combination suggests a broader cholesterol-synthesis disorder rather than isolated gonadal dysgenesis.
Moderate
Biochemical evidence of impaired cholesterol synthesis
A confirmed pathway abnormality supports the metabolic diagnosis when interpreted clinically.
High
Choose 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 when
Mosaic 45,X/46,XY karyotype
Documented mosaicism is central to mixed gonadal dysgenesis.
High
Asymmetric or streak gonadal tissue
These findings fit mixed gonadal dysgenesis better than a primary cholesterol defect.
Moderate
Turner-like features with variable genital development
This pattern prompts chromosomal mosaicism evaluation.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Interpretation |
|---|---|---|---|
| Karyotype | Typically 46,XY, without defining mosaicism. | 45,X/46,XY mosaicism may be detected. | Karyotype strongly separates chromosomal mosaicism from a metabolic 46,XY condition. |
| Cholesterol-pathway studies | May show a cholesterol-synthesis abnormality. | No specific cholesterol-pathway abnormality is expected. | Abnormal results support, but do not independently diagnose, the metabolic condition. |
| Gonadal imaging or histology | Findings vary and are not diagnostic alone. | May show streak, testicular, or mixed gonadal tissue. | Tissue findings require correlation with karyotype and clinical assessment. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
- Outcome
- Often a severe, lifelong multisystem condition; exact outcomes vary.
- Factors
- Syndrome severity, developmental effects, and endocrine needs.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
- Outcome
- Often moderate but highly variable; many outcomes depend on anatomy and hormones.
- Factors
- Mosaicism distribution, gonadal findings, growth, and associated anomalies.
Time frame: Both are congenital and chronic; reliable comparative survival data are not supplied.
Individual diagnosis, associated anomalies, and access to specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Endocrine insufficiency | Sex-hormone production may be impaired and need specialist support. Pubertal development and gonadal hormone production may be variable. Hormone plans are individualized; no dose is implied. |
| Gonadal risk | Specific tumor risk is not established by the supplied data. Dysgenetic gonadal tissue may warrant surveillance or specialist risk assessment. Decisions require multidisciplinary review. |
| Associated health issues | Broader congenital, growth, or developmental complications may occur. Short stature, cardiac, renal, or Turner-associated issues may need evaluation. Screening should follow clinician judgment, not a fixed protocol here. |
Patient education highlights
- HighDiagnosis
These conditions are distinguished by genetics and biochemistry, not appearance alone.
- HighCare team
Endocrinology, genetics, and other specialists may coordinate lifelong care.
- MediumResults
An abnormal laboratory or imaging result is not automatically a complete diagnosis.